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Objectives: To determine the validity of using UBCO2G
for monitoring sick children with cardiac disease.
Design: A prospective, observational non interventional
cohort study.
Setting: King Abdul Aziz Medical City, Pediatric Cardiac
ICU (PCICU), Riyadh.
Patients: Between April 2011 and May 2013, 257 patients
admitted to our PCICU were recruited in the study.
Intervention: Arterial and central venous blood samples
were collected as needed per patients’ conditions.
Patients’ clinical and laboratory data were collected
simultaneously.
Results: A total of 421 data sets with arterial, upper (SVC)
and lower (FV) body central venous PCO2 were collected
spontaneously from 257 patients age 17.0 ± 25.8 months,
weight 7.45 ± 5.53 kg. UBPCO2G was higher than lower
(art-FV) body PCO2 (LBPCO2G) gap 7.80 ± 3.28 vs.
5.95 ± 3.65 mmHg (p = 0.001. In 75% of our data sets
UBPCO2G was 69.65 and LBPCO2 gap was 67.8 mmHg.
Patients with UBPCO2G P9.65 vs. <9.65 mmHg had
higher lactic acid (LA) 2.0 ± 1.4 vs. 1.6 ± 1.3 mmol/L
(p = 0.014), BUN 6.1 ± 5.2 vs. 4.8 ± 2.1 mmol/L (p = 0.013),
creatinine 48 ± 17 vs. 43 ± 13 lmol/L (p = 0.004), glucose
8.7 ± 4.1 vs. 7.1 ± 3.7 mmol/L (p = 0.001) and PRISM score
9 ± 6 vs. 7 ± 6 (p = 0.038) and lower urine output 5.2 ± 2.8
vs. 6.1 ± 4.3 ml/kg/3 h. However patients with UBPCO2G
P6 vs. <6 mmHg were different in LA only 1.8 ± 1.5 vs.
1.5 ± 1.0 mmol/L, respectively (p = 0.018).
Conclusion: Upper is higher than lower body PCO2gap.
UBPCO2G P9.65 was associated with higher LA, BUN,
creatinine, serum glucose and PRISM and lower urine
output. Patients with UBPCO2G P9.65 were sicker.
UBPCO2G can be used as a biomarker in monitoring chil-
dren with cardiac disease.
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